From Needle to Pill: Oral PCSK9 Inhibition Enters the Lipid-Lowering Armamentarium.

Cardiovascular diseases

Care/Management

Authors

Belancic Belancic, Borovac Borovac

Share

Facebook

X (Twitter)

Bluesky

Linkedin

Copy to clipboard